Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mind Medicine (MindMed) Inc. (MNMD:NASDAQ), powered by AI.
Mind Medicine (MindMed) Inc. is currently trading at $24.16. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mind Medicine (MindMed) Inc. on Alpha Lenz.
View Mind Medicine (MindMed) Inc.'s valuation metrics on Alpha Lenz.
“Mind Medicine (MindMed) Inc.'s ROE is -64.1%. Explore profitability and growth together.”
Ask for details →Mind Medicine (MindMed) Inc. is a biopharmaceutical company focused on developing psychedelic-inspired medicines and therapies. The primary purpose of MindMed is to innovate treatments for mental health disorders such as anxiety, ADHD, depression, and addiction. By leveraging substances like LSD and psilocybin, the company aims to pioneer new approaches within psychiatric and neurological health sectors. MindMed is at the forefront of integrating psychedelic research into mainstream medical practices, contributing to a growing field exploring non-traditional treatment options. With ongoing clinical trials and significant advancements in its drug development pipeline, MindMed plays a vital role in the shift towards alternative mental health solutions. The company's efforts align with a broader movement in the healthcare industry seeking to destigmatize and scientifically validate the use of psychedelics as viable therapeutic options, positioning itself as a key player in the evolution of psychiatric care.
“Mind Medicine (MindMed) Inc.'s ROE is -64.1%. Explore profitability and growth together.”
Ask for details →Mind Medicine (MindMed) Inc. (ticker: MNMD) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 74 employees.
The current price is $24.16 with a P/E ratio of -x and P/B of -x.
ROE is -64.06%.